Amundi Ginkgo Bioworks Holdings, Inc. Transaction History

Amundi

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $28,124 - $44,310	26,533 Added 8.83%	327,153 $379,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $83,588 - $118,748	66,340 Added 28.32%	300,620 $508,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $70,403 - $111,071	43,729 Added 22.95%	234,280 $424,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $22,051 - $40,243	18,376 Added 10.67%	190,551 $253,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $280,645 - $606,056	172,175 New	172,175 $290,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $133,031 - $253,969	60,469 Added 102.47%	119,480 $369,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $126,017 - $386,957	44,529 Added 307.48%	59,011 $201,000
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $132,510 - $192,320	14,482 New	14,482 $168,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.